ADAP
Adaptimmune Therapeutics
ADAP
ADAP
87 hedge funds and large institutions have $637M invested in Adaptimmune Therapeutics in 2020 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 19 closing their positions.
Holders
87
Holders Change
+8
Holders Change %
+10.13%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
27
Increased
27
Reduced
19
Closed
19
Calls
$1.23M
Puts
$767K
Net Calls
+$463K
Net Calls Change
-$522K